The delay, narrowed approval, and extra study steps raise concerns about the status of and potential added requirements for other COVID vaccines.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
A randomized trial in Canada finds that COVID-19 patients in the audit and feedback group had lower antibiotic use but similar outcomes to patients treated with standard of care.
The bivalent booster offered additional benefits against symptomatic infection and severe illness, 3 new studies show.
In another COVID development, the FDA pulled its EUA for Evusheld, the last available monoclonal antibody treatment, due to weak activity against the newer circulating subvariants.
Residents not up to date on recommended COVID-19 vaccines were at a 30% to 50% higher risk for infection.
Data show the share of Americans reporting long COVID has dropped over the past 6 months, while another study suggests vaccination may contribute to lower levels of long COVID.
FDA advisers recommend offering just the newer bivalent versions of the vaccine for both primary and booster series.
The study shows people with dementia faced continued challenges in care even after the acute phase of the pandemic.
The state will launch a pilot program to test wastewater for flu, hepatitis A, norovirus, and antimicrobial-resistance genes.
Global cases have declined 25% in the previous 4 weeks, but deaths rose 13%.
The positivity rate of home tests was comparable to official results through June 2022 but then started to drop off.
